Chester R Willis

Title: The Innovations of Chester R. Willis

Introduction

Chester R. Willis is a notable inventor based in Blackwood, NJ (US), recognized for his contributions to the field of pharmaceuticals. With a total of four patents to his name, Willis has made significant strides in developing compounds that address allergic conditions.

Latest Patents

Willis's latest patents include "Substituted 2H-pyran-2,6(3H)-dione derivatives," which are useful in the treatment of allergic conditions. These derivatives are prepared by the reaction of 3,5-diacetyl-4,6-dihydroxy-2H-pyran-2-one with an appropriate aniline. Another significant patent is for "Substituted aurones," which serve as inhibitors of certain antigen-antibody reactions, particularly in alleviating allergic manifestations such as asthma. These aurones are synthesized by reacting a 3-coumaranone with an appropriately substituted benzaldehyde, followed by treatment with aqueous mineral acid and an alkanol.

Career Highlights

Chester R. Willis is currently employed at SmithKline Corporation, where he continues to innovate and develop new pharmaceutical solutions. His work has had a profound impact on the treatment of allergies, showcasing his dedication to improving health outcomes.

Collaborations

Throughout his career, Willis has collaborated with esteemed colleagues such as Kenneth M. Snader and Lawrence William Chakrin. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

Chester R. Willis exemplifies the spirit of innovation in the pharmaceutical industry. His patents and ongoing work at SmithKline Corporation highlight his commitment to addressing critical health issues related to allergies.